Inhibikase Therapeutics, Inc.
IKT
$1.67
$0.000.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 170.37M | 178.76M | 77.32M | 87.67M | 93.18M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.27M | 318.40K | 593.80K | 657.60K | 907.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 539.90K | 1.03M | 620.60K | 471.20K | 77.50K |
| Total Current Assets | 172.18M | 180.11M | 78.54M | 88.79M | 94.16M |
|
|
|||||
| Total Current Assets | 172.18M | 180.11M | 78.54M | 88.79M | 94.16M |
| Net Property, Plant & Equipment | -- | -- | 0.00 | 58.60K | 116.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.16M | 1.10M | 1.06M | -- | -- |
| Total Assets | 173.33M | 181.20M | 79.59M | 88.85M | 94.28M |
|
|
|||||
| Total Accounts Payable | 1.59M | 1.16M | 620.50K | 2.70M | 1.69M |
| Total Accrued Expenses | 4.12M | 4.08M | 3.66M | 3.15M | 3.51M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 37.90K | 74.80K |
| Total Finance Division Other Current Liabilities | -- | 3.06M | 2.42M | 2.91M | 3.27M |
| Total Other Current Liabilities | -- | 3.06M | 2.42M | 2.91M | 3.27M |
| Total Current Liabilities | 5.71M | 8.30M | 6.70M | 8.80M | 8.55M |
|
|
|||||
| Total Current Liabilities | 5.71M | 8.30M | 6.70M | 8.80M | 8.55M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.71M | 8.30M | 6.70M | 8.80M | 8.55M |
|
|
|||||
| Common Stock & APIC | 326.71M | 315.56M | 202.85M | 198.07M | 193.83M |
| Retained Earnings | -159.06M | -142.68M | -129.95M | -118.01M | -108.10M |
| Treasury Stock & Other | -26.30K | 21.80K | -4.20K | -2.90K | -1.00K |
| Total Common Equity | 167.62M | 172.90M | 72.90M | 80.05M | 85.73M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 167.62M | 172.90M | 72.90M | 80.05M | 85.73M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 167.62M | 172.90M | 72.90M | 80.05M | 85.73M |
|
|
|||||